Historical Context & Motivation
For most of medical history, myocardial infarction (MI) was a death sentence. Clinicians observed that patients who survived the initial ischemic insult frequently deteriorated within hours to days—some developing chaotic heart rhythms, others progressing to florid pump failure—yet the mechanistic links between infarction and these sequelae remained obscure. The modern understanding that MI sets off a cascade of electrical, structural, and neurohormonal derangements is the product of more than a century of investigation at the intersection of pathology, electrophysiology, and clinical cardiology.
The central question this lesson addresses is: How does an acute myocardial infarction mechanistically give rise to arrhythmias and heart failure, and why are these complications so tightly linked to the underlying cellular injury? Answering this question requires integrating knowledge of myocardial electrophysiology, hemodynamics, and neurohormonal regulation—domains that converge at the site of infarcted tissue.
Core Principles & Definitions
Before examining specific complications, it is essential to establish the foundational concepts that govern how an MI disrupts normal cardiac function. The myocardium depends on an uninterrupted supply of oxygenated blood; when a coronary artery becomes occluded—typically by a ruptured atherosclerotic plaque and superimposed thrombus—the downstream tissue undergoes progressive ischemic injury. If perfusion is not restored within minutes to hours, irreversible coagulative necrosis ensues. The necrotic zone, the surrounding border zone of injured but viable tissue, and the remote unaffected myocardium each respond differently, creating a heterogeneous milieu that is the breeding ground for complications.
Ischemic Cascade
Arrhythmogenesis
Ventricular Remodeling
Neurohormonal Activation
Temporal Classification
Visual Overview: From Infarct to Complication
As the diagram makes clear, the complications of MI are not isolated events but rather interconnected consequences of the same primary insult. The electrical pathway (left branch) and the mechanical/hemodynamic pathway (right branch) share a common origin in ischemia-induced cellular injury and continuously feed back on each other. A patient in ventricular tachycardia loses effective cardiac output, precipitating acute hemodynamic collapse; conversely, a failing ventricle with elevated wall stress and catecholamine exposure provides fertile ground for re-entrant arrhythmias. Clinically, this bidirectional relationship explains why aggressive treatment of one pathway often ameliorates the other—beta-blockers, for example, reduce both arrhythmia burden and neurohormonal overdrive.
Mechanism Deep Dive: Cellular & Molecular Pathways
Arrhythmia Mechanisms After MI
The electrophysiological substrate for post-MI arrhythmias evolves over time and involves three well-characterized mechanisms. Re-entry is the most clinically significant and arises when an electrical impulse propagates around a fixed anatomical obstacle—the dense scar—or through a functionally heterogeneous border zone where conduction velocities differ. For re-entry to occur, three conditions must be met: a unidirectional conduction block, a pathway of slow conduction, and sufficient path length such that the initially blocked tissue recovers excitability by the time the circulating wavefront returns.
Enhanced automaticity occurs when partially depolarized myocytes in the border zone reach threshold more readily than normal, generating spontaneous impulses that compete with the sinus node. Accumulation of extracellular K⁺ during ischemia shifts the resting membrane potential from approximately −90 mV to −60 mV, inactivating fast Na⁺ channels and allowing slow-response Ca²⁺-dependent automaticity to emerge. Triggered activity represents the third mechanism and results from abnormal oscillations of membrane potential (afterdepolarizations). Delayed afterdepolarizations (DADs) are driven by intracellular Ca²⁺ overload, which activates the Na⁺/Ca²⁺ exchanger in forward mode, generating a transient inward current. If this current reaches threshold, a premature beat is triggered, potentially initiating sustained tachycardia.
Heart Failure Mechanisms After MI
Post-MI heart failure is fundamentally a disease of ventricular remodeling. In the acute phase (hours to days), loss of contractile mass directly reduces stroke volume. The Frank-Starling mechanism attempts to compensate: the remaining viable myocardium increases its end-diastolic volume to generate greater force of contraction. However, this compensation has limits. The Law of Laplace describes wall stress (σ) in the ventricle, illustrating why dilation is a double-edged sword.
Neurohormonal activation compounds the problem. Reduced cardiac output triggers baroreceptor-mediated sympathetic nervous system (SNS) activation, which increases heart rate and contractility in the short term but chronically desensitizes β₁-adrenergic receptors and promotes apoptosis of viable myocytes. Simultaneously, reduced renal perfusion activates the renin-angiotensin-aldosterone system (RAAS), leading to angiotensin II–mediated vasoconstriction, aldosterone-driven sodium and water retention, and TGF-β–mediated interstitial fibrosis. These processes collectively increase preload and afterload while degrading the remaining myocardial architecture—a self-perpetuating cycle that defines progressive heart failure.
Temporal Classification of Post-MI Complications
Post-MI complications do not occur randomly; they follow a relatively predictable temporal sequence dictated by the evolving pathology of the infarcted myocardium. Clinicians organize complications into immediate (minutes to hours), early (hours to days), and late (weeks to months) phases, each dominated by distinct mechanistic drivers. The following diagram maps the major arrhythmic and heart failure complications onto a timeline of infarct evolution.
| Phase | Arrhythmia Type | Predominant Mechanism | HF Manifestation |
|---|---|---|---|
| Immediate (0−6 hrs) | VF, polymorphic VT, sinus brady/AV block (if inferior MI) | Enhanced automaticity; triggered activity (K⁺ efflux, Ca²⁺ overload) | Cardiogenic shock (if ≥40% LV involved) |
| Early (6 hrs−7 days) | Accelerated idioventricular rhythm; reperfusion arrhythmias | Reperfusion-related automaticity; residual ion imbalance | Acute MR (papillary muscle), VSD, pericarditis |
| Late (weeks−months) | Monomorphic VT; sudden cardiac death | Scar-based re-entry; gap-junction remodeling | Chronic HFrEF; ventricular aneurysm |
Worked Example: Clinical Case Analysis
The following clinical vignette integrates the pathophysiological mechanisms discussed above. Work through each step to trace how an acute MI produces its complications in a specific patient.
Comparing Arrhythmic vs. Heart Failure Pathways
While arrhythmias and heart failure both arise from the same ischemic insult, they differ fundamentally in their temporal profiles, dominant cellular mechanisms, and therapeutic targets. Understanding these distinctions—and their points of convergence—is essential for clinical reasoning. The table below provides a systematic comparison across multiple dimensions.
| Dimension | Arrhythmias | Heart Failure |
|---|---|---|
| Primary Cell Target | Conduction system & border-zone myocytes (ion channels, gap junctions) | Contractile myocytes & extracellular matrix (sarcomeres, collagen) |
| Key Molecular Drivers | K⁺ efflux, Ca²⁺ overload, connexin-43 dephosphorylation, Na⁺ channel inactivation | RAAS activation, norepinephrine excess, TGF-β–mediated fibrosis, MMP activation |
| Onset | Seconds to minutes (acute phase); weeks to months (chronic scar re-entry) | Hours to days (acute decompensation); weeks to months (chronic remodeling) |
| Clinical Presentation | Palpitations, syncope, sudden cardiac arrest | Dyspnea, orthopnea, peripheral edema, fatigue |
| Primary Therapeutic Target | Electrical stability: antiarrhythmics, ICD, catheter ablation | Neurohormonal blockade: ACE-I/ARB, β-blockers, MRA, ARNI |
| Shared Intervention | β-blockers reduce both arrhythmia burden and neurohormonal overdrive | β-blockers reduce both arrhythmia burden and neurohormonal overdrive |
Connection to Advanced Concepts
The introductory framework presented in this lesson lays the groundwork for several advanced topics you will encounter in later courses. Understanding how MI produces arrhythmias and heart failure through discrete yet overlapping pathways prepares you for deeper study of electrophysiology, advanced heart failure management, and molecular cardiology.
| This Lesson (Introductory) | Advanced Concept |
|---|---|
| Re-entry as a mechanism of VT | Electrophysiology study (EPS) and programmed stimulation to map re-entrant circuits; catheter ablation of scar-related VT |
| RAAS activation and remodeling | Molecular pharmacology of ARNI (sacubitril/valsartan), SGLT2 inhibitors, and their impact on reverse remodeling |
| Wall stress and Laplace's Law | Pressure-volume loop analysis; hemodynamic assessment with Swan-Ganz catheterization; mechanical circulatory support (IABP, Impella) |
| Gap-junction remodeling (connexin-43) | Cardiac optogenetics; gene therapy targeting gap-junction proteins; computational arrhythmia modeling |
| Bidirectional arrhythmia–HF link | Cardiac resynchronization therapy (CRT); ICD with HF monitoring algorithms; arrhythmia-induced cardiomyopathy |
One particularly important advanced concept is arrhythmia-induced cardiomyopathy, in which chronic tachyarrhythmias—even those of moderate rate—can independently cause ventricular dilation and systolic dysfunction, mimicking a primary cardiomyopathy. This concept, which may seem counterintuitive, underscores the bidirectional mechanism link: in some patients, the arrhythmia is not merely a complication of heart failure but its direct cause. Recognition and successful treatment of the arrhythmia can lead to complete recovery of ventricular function, a phenomenon known as reverse remodeling. These advanced topics build directly on the mechanistic foundations established in this introductory lesson.
Practice Problems
Lesson Summary
Myocardial infarction initiates a cascade of complications through two interconnected pathological pathways. The electrical pathway begins with ischemia-driven ionic derangements — K⁺ efflux and Ca²⁺ overload — that produce arrhythmias through three mechanisms: re-entry (wavelength λ = CV × ERP shortened by slow conduction and reduced refractoriness), enhanced automaticity (partial depolarization of border-zone cells), and triggered activity (Ca²⁺-dependent delayed afterdepolarizations). Immediate arrhythmias are metabolically driven, while late arrhythmias depend on fixed scar-based re-entry circuits.
The hemodynamic/mechanical pathway follows from loss of contractile mass, which reduces stroke volume and cardiac output (CO = SV × HR). The Law of Laplace (σ = Pr/2h) explains how wall thinning and chamber dilation escalate wall stress, which triggers neurohormonal activation (SNS and RAAS) that initially compensates but chronically drives adverse ventricular remodeling and progressive heart failure. Crucially, the two pathways are bidirectionally linked: arrhythmias worsen hemodynamics, and heart failure creates a proarrhythmic substrate. This interdependence explains why therapies such as β-blockers, which target both pathways simultaneously, are cornerstones of post-MI management.